Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Step-Edge Functionalization by N-Heterocyclic Carbenes Enhances Catalytic Activity in Electrochemical CO<sub>2</sub> Reduction.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Telomerase is induced during wound healing across species.

Skin health and disease·2026
Same author

A high-throughput modular microfluidic platform for versatile functional assays at single-cell level.

Microsystems & nanoengineering·2026
Same author

Telomerase mRNA-Lipid nanoparticles attenuate neuroinflammation after traumatic brain injury in mice.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same author

Cytosine base editing of LPA in transgenic mice averts large deletions.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Organic neuromorphic vision devices with multilevel memory for palmprint identification.

Chemical science·2026

Related Experiment Video

Updated: Jun 26, 2026

Development of New Therapeutic Applications Using Microfluidics
08:56

Development of New Therapeutic Applications Using Microfluidics

Published on: October 1, 2007

Nanomedicine--challenge and perspectives.

Kristina Riehemann1, Stefan W Schneider, Thomas A Luger

  • 1Center for Nanotechnology und Physikalisches Institut, Westfälische Wilhelms-Universität Münster, Wilhelm-Klemm-Strasse 10, 48149 Münster, Germany. k.riehemann@uni-muenster.de

Angewandte Chemie (International Ed. in English)
|January 15, 2009
PubMed
Summary

Nanomedicine merges nanotechnology and medicine, offering significant societal and economic potential. This review highlights recent advancements in nanomedicine applications, while acknowledging toxicological and ethical considerations.

More Related Videos

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

Related Experiment Videos

Last Updated: Jun 26, 2026

Development of New Therapeutic Applications Using Microfluidics
08:56

Development of New Therapeutic Applications Using Microfluidics

Published on: October 1, 2007

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Molecular Biology

Background:

  • Nanotechnology and medicine are merging, creating significant societal and economic potential.
  • The convergence leverages molecular-scale properties for advanced applications.
  • Nanomedicine utilizes nanoscale characterization and chemical modification of surfaces.

Purpose of the Study:

  • To provide an overview of recent developments and applications in nanomedicine.
  • To explore the interdisciplinary nature of nanomedicine.
  • To address the toxicological and ethical implications of nanomedicine.

Main Methods:

  • Review of recent scientific literature on nanomedicine.
  • Analysis of applications in targeted drug delivery, molecular imaging, and neuroprosthetics.
  • Discussion of characterization techniques at the nanometer scale.

Main Results:

  • Nanomedicine enables precise surface and interface characterization using local probes and molecular imaging.
  • Chemical approaches facilitate targeted drug delivery, enhanced biocompatibility, and neuroprosthetic development.
  • Significant potential exists, but toxicological and ethical concerns require careful consideration.

Conclusions:

  • Nanomedicine represents a powerful interdisciplinary field with vast potential.
  • Recent advancements showcase innovative applications in healthcare.
  • Responsible development necessitates addressing safety and ethical challenges.